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Mechanical forces play key roles throughout biology. Most existing methods
for probing forces in/between molecules and cells, such as the AFM, optical
tweezers, magnetic tweezers, traction force microscopy, etc., require molecules
to be tethered to the surfaces of cover glasses or beads. However, surface teth-
ering has a number of drawbacks. First, the conjugation chemistry for tethering
can be challenging. Second, the spatial confinement and the nonspecific attrac-
tion from the surface can induce artifacts to the dynamics of the molecule. For
semi-rigid objects, such as actin filaments, surface attachment could also
induce bending and twisting of the filament, complicating the applied force pro-
file. To overcome these issues, we present a surface-free force spectroscopy
method that uses a high-speed cross-slot hydrodynamic trap, capable of stretch-
ing molecules and cells with hydrodynamic drag. The trap is based on a glass
microfluidic cross-slot flow chamber. Buffer flows in from two opposite direc-
tions and exits via the two orthogonal outlets to create an elongational flow field
with a stagnation point in the center. As a result, objects near the stagnation
point are stretched by the viscous drag from the flow. In addition, the pressure
in one of the outlet reservoirs is electronically controlled with a high-speed
feedback algorithm to stabilize the object at the stagnation point. Thanks to
the high-speed feedback, we can apply much higher flow rate and therefore
much higher stretching force on the trapped object than with the cross slot
alone. We demonstrate tension-dependent actin severing, extension of vonWil-
lebrand Factor (a key protein in haemostasis that changes conformation in
response to hydrodynamic stress in blood stream), overstretching of double
strand DNA, and stretching deformation of red blood cells. In summary, the
high-speed cross-slot hydrodynamic trap can be a powerful, surface-free alter-
native to more commonly used force spectroscopy methods.
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The forced disruption of the (strept)avidin-biotin complex by atomic force mi-
croscopy (AFM) and other techniques opened the field and established the basis
of single molecule force spectroscopy (1-3). Steered molecular dynamics
(SMD) simulations provided atomic description of the unbinding process (4).
However, the maximum experimental AFM velocities were typically of
10 mm/s, while SMD simulations were performed in the range of 1 m/s to
10 m/s. Recent development of high-speed force spectroscopy (HS-FS) using
HS-AFM allowed velocities in the mm/s range (5). We have applied HS-FS
to probe the binding strength of the streptavidin-biotin complex at velocities
up to ~8 mm/s, paralleled by SMD simulations. The experimental dynamic
force spectrum of the unbinding process is compared with SMD simulations.
The combination of HS-FS and SMD at overlapping velocities provides an
atomic description of the unbinding process measured by experiment.
1. Merkel, R., P. Nassoy, A. Leung, K. Ritchie, and E. Evans. 1999. Energy
landscapes of receptor-ligand bonds explored with dynamic force spectros-
copy. Nature 397:50-53.
2. Florin, E. L., V. T. Moy, and H. E. Gaub. 1994. Adhesion Forces Between
Individual Ligand-Receptor Pairs. Science 264:415-417.
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Single molecules of integrins, a class of trans-membrane proteins involved in
cell adhesion, experience a peak force of 40 pN through their ligands during
initial adhesion. This force requirement was determined using a series of dou-
ble stranded (ds) DNA tethers, each with a different rupture force, conjugated
to the ligand. Here, force spectroscopy is performed by multiplexing two typesof DNA tethers on the same surface: one that requires a strong rupture force
(54 pN) and the other, a weak rupture force (12 pN). When presented alone,
cells adhere to the strong tethers but not the weak tethers. However, when mul-
tiplexed, the result is synergistic; cells can adhere to a surface displaying just a
few molecules of the strong tether if, and only if, they are presented along with
many weak tethers. This degree of ultra-sensitivity raises a question on how
cells suppress noise during decision making based on nano-mechanical
environments.
Platform: Protein-Small Molecule Interactions
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Kira A. Armacost, Garrett B. Goh, Charles L. Brooks.
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Traditional free energy calculations are known for their issues with scalability,
speed and convergence.Wehave recently developed the biasingpotential replica
exchange multi-site l-dynamics (BP-REX MSlD) method, which is a free en-
ergy method capable of transforming multiple substituents at multiple sites on
a common framework with relative ease. With this methodology, we are able
to show convergence of flexible moieties for symmetric benzoquinone deriva-
tives, and have developed a series of metrics capable of increasing the l-space
sampling.We grouped and ordered the substituents based on volume occupancy,
and were able to compute the free energy of binding for a series of challenging
geldanamycin-derivatives for heat shock protein 90. The perturbations spanned
by asmuch as 60 A˚3 andwewere able tomodel thesewith a 2.4 kcal/mol average
unsigned error. These metrics coupled with BP-REX MSlD allow for routine
calculations on the order of hundreds of compounds in a few simulations.
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While it is currently estimated that 40-50% of eukaryotic proteins are phos-
phorylated, little is known about the frequency and local effects of phosphory-
lation near pharmaceutical inhibitor binding sites. In this study, we investigated
how frequently phosphorylation may affect the binding of drug inhibitors to
target proteins. We examined the 453 non-redundant structures of soluble
mammalian drug target proteins bound to inhibitors currently available in the
Protein Data Bank (PDB). We cross-referenced these structures with phosphor-
ylation data available from the PhosphoSitePlus database. 322/453 (71%) of
drug targets have evidence of phosphorylation that has been validated by mul-
tiple methods or labs. For 132/453 (29%) of those, the phosphorylation site is
within 12A˚ of the small molecule-binding site, where it would likely alter small
molecule binding affinity. We propose a framework for distinguishing between
drug-phosphorylation site interactions that are likely to alter the efficacy of
drugs vs. those that are not. In addition we highlight examples of well-
established drug targets, such as estrogen receptor alpha, for which phosphor-
ylation may affect drug affinity and clinical efficacy. Our data suggest that
phosphorylation may affect drug binding and efficacy for a significant fraction
of drug target proteins.
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Emerging resistance of Plasmodium falciparum to current treatments is con-
cerning and requires the development of a new generation of drugs. In pursuit
of novel compounds, we have targeted protein-protein interactions (PPIs)
essential to the parasite.
Plasmodium uses an actomyosin motor, part of the glideosome complex, for
gliding and invasion of host cells. A key interaction of the glideosome is be-
tween aldolase and the cytoplasmic tail of the thrombospondin-related adhesive
protein, TRAP. It is thought that the dynamic aldolase-TRAP complex must
dissociate for forward motility and invasion to progress; therefore, we have
developed an assay to identify compounds that promote this interaction, result-
ing in stalled gliding and invasion.
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tion between aldolase and TRAP using surface plasmon resonance. We have
screened the Medicines for Malaria Ventures library and have identified several
compounds with concentration-dependent effects in vitro. Five promising com-
pounds were moved forward into parasite gliding and invasion assays. We have
observed phenotypic differences in the ability of Plasmodium parasites to glide,
and found a reduced gliding velocity and abnormal rates of sporozoite attach-
ment and detachment. To determine the effect on invasion, both red blood cell
and hepatocyte invasion assays have been performed.We are currently attempt-
ing to determine a co-crystal structure of the ternary aldolase-TRAP-compound
complex, and to move promising compounds into an in vivo mouse model.
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Computational approaches have been increasingly employed for drug discov-
ery in both academia and industry. The ultimate goal of rational drug design
is the prediction of the biological activity of a compound, and such activity
is driven, at the molecular level, by the specific intermolecular interactions be-
tween the small organic molecule, the biological target and the solvent. Similar
molecular recognition processes are crucial for many biological functions and
the strength of the recognition is characterized by its binding affinity. Thanks to
important advances in theory and computing in the last decades, predictions of
binding affinities using physics-based simulations are gaining popularity. In
particular, binding free energy estimates based on alchemical pathways have
been shown to be a rigorous approach for the affinity prediction problem and
hold the promise to be able to guide lead optimisation. However, whilst relative
calculations have made significant contributions in a drug-discovery context,
absolute calculations have so far been mostly applied to model systems despite
the advantages related to the ability to estimate affinities for largely diverse sets
of molecules.
We present the results of a study where we evaluated the performance of
alchemical free energy estimates for a set of drug-like molecules that have
been developed to target bromodomains, a family of epigenetic marks readers
with established therapeutic potential. The study evaluates the performance of
the protocol employed from a retrospective and perspective standpoint, with
particular attention to the precision of the calculations and comparing the theo-
retical results with high-quality binding data. We show that, for this epigenetic
target, good agreement between calculations and experiments is achievable
even for very challenging compounds, suggesting that alchemical free energy
calculations might be approaching the degree of reliability required in order
to have an impact in drug discovery campaigns.
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Marta M. Wells, David D. Mowrey, Edom Seyoum, Tianmo Sun, Yan Xu,
Pei Tang.
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Human glycine receptors (hGlyRs) are important targets for neuroactive drugs,
including for analgesic therapies. A previous study has identified the crucial
role of residue S296 in hGlyR-a1 potentiation by D9-tetrahydrocannabinol
(THC) and in cannabinoid-induced analgesia. The recently determined NMR
structure of the hGlyR-a1 transmembrane domain (TMD) provides a basis
for structure-based virtual screening to discover new analgesic drugs. Using
a large ensemble of hGlyR-a1 structures generated from molecular dynamics
simulations based on the NMR structure, we screened 1549 FDA approved
compounds from the DrugBank database targeted to a cannabinoid binding
site near residue S296. Drugs were ranked based on their predicted binding af-
finities across the ensemble of hGlyR-a1 TMD structures. Four leading com-
pounds were selected for experimental validation in Xenopus laevis oocytes
expressing hGlyR-a1. At a low concentration (1 mM), all four leading com-
pounds potentiate hGlyR-a1 currents more than two times, which was greater
than that of THC. The hit rate is remarkable. The study provides strong evi-
dence that these leading compounds will be at least as effective as THC for
analgesia by acting on hGlyR-a1, but without psychoactive effects. The proto-
col developed here can easily be applied to the discovery of novel analgesic
compounds of even higher efficacy on hGlyRs. Research supported by grants
from the NIH and XSEDE.1793-Plat
Green and Black Tea Polyphenols Mechanistically Inhibit the Aggregation
of Amyloid-b in Alzheimer’s Disease
Shelby E. Chastain1, Melissa Moss2.
1Biomedical Engineering, University of South Carolina, Columbia, SC, USA,
2Chemical Engineering, University of South Carolina, Columbia, SC, USA.
Alzheimer’s disease (AD) is the 6th leading cause of death and is the only dis-
ease among the top 10 that cannot be prevented, cured or treated. The amyloid
cascade hypothesis states that naturally occurring amyloid-b (Ab) monomer
aggregates via a nucleation-dependent pathway to form soluble aggregates
and insoluble fibrils that deposit as plaques in the brain. Consequently, inhibi-
tion of Ab aggregation is one therapeutic strategy for AD. This study sought to
explain epidemiological correlations between frequent tea consumption and
reduced incidence of AD by identifying the Ab aggregation inhibitory capabil-
ities of key polyphenol components in green and black tea.
Polyphenols studied include green tea catechins, epicatechin, epigallocatechin
and epigallocatechin gallate, as well as black tea theaflavins, theaflavin and the-
aflavin monogallate. Four assays were used to target unique steps along the ag-
gregation pathway: a monomer aggregation assay to monitor the overall
aggregation process; an oligomerization assay to monitor the initial nucleation
step; an association assay to monitor the late stage lateral binding of soluble
aggregates; and an elongation assay to monitor the late stage lengthening of sol-
uble aggregates.
Catechins and theaflavins show different inhibitory capabilities at varying
mechanistic steps of the Ab aggregation pathway. Catechins affect only the
later stages of aggregation, suggesting that catechins may bind a specific struc-
ture present in aggregates. Conversely, theaflavins show inhibitory capabilities
at every stage of aggregation, alluding to a sequence specific recognition.
Furthermore, better inhibitory capabilities, for both polyphenol categories,
can be correlated with the number of gallate groups.
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Alina A. Pashkovskaya, Elena E. Pohl.
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Reactive aldehydes (RA) are involved in the onset and progression of many pa-
thologies such as cardiovascular and neurodegenerative diseases. The precise
mechanisms by which aldehydes contribute to these diseases remain unclear.
Previously, we and other groups suggested that RAs modify the membrane
protein function by either binding to the proteins directly(1) or to aminophos-
phosholipids, with a subsequent alteration in protein conformation. Here,
we investigated the influence of biologically important RAs such as 4-hy-
droxy-2-nonenal (HNE), 4-oxo-2-nonenal (ONE) and 4-hydroxy-2-hexenal
(HHE) on the transport kinetics of the ionophores carbonyl-cyanide-m-
chlorophenylhydrazone (CCCP) and valinomycin (Val). We found that RA in-
creases the membrane conductance, G, in the presence of Val in the following
order ONE>HNE>HHE. In contrast G decreases in the presence of CCCP and
ONE. The presence of phosphatidylethanolamine in the membrane was crucial
for the effect to occur. The results are consistent with the hypothesis that RA
adducts alter membrane boundary potential.
1. E. A. Malingriaux, et al., ‘‘Fatty Acids are Key in 4-Hydroxy-2-Nonenal-
Mediated Activation of Uncoupling Proteins 1 and 2’’ PLoS. ONE. 8(10),
e77786 (2013).
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Understanding the specificity of kinase inhibitors has tremendous therapeutic
significance. To predict inhibitor selectivity computationally, an iterative
approach incorporating experimental measurements is ideal. This work de-
scribes the development of a high-throughput label-free fluorescent ligand-
binding assay to measure inhibitor affinities. Taking advantage of the intrinsic
fluorescence increase of a group of FDA-approved kinase inhibitors upon bind-
ing kinases, we are able to measure inhibitor binding affinity with small
amounts of protein and without any fluorescent labels. This facilitates rapid
characterization of a wide range of kinase inhibitors and kinase resistance mu-
tants, within a system that can be reproduced identically in molecular dynamics
simulations.
